Show results for
Refine by
Pharma Develops Intermediates Articles & Analysis
16 articles found
Huateng Pharma, a leading Contract Development and Manufacturing Organization (CDMO), is proud to announce the launch of its latest product, Piroctone Olamine (CAS: 68890-66-4). ...
In later clinical applications, doctors observed hair regrowth and generalized excessive hair in balding patients, which led to the development of minoxidil preparations. Minoxidil can increase local blood supply, stimulate the proliferation and differentiation of hair follicle epithelial cells, so as to promote hair growth and achieve the purpose of treating hair loss. ...
Diabetes is a chronic disease that affects more than 540 million people worldwide and is one of the leading causes of death and disability worldwide. In China, there are more than 114 million adults with diabetes, accounting for about a quarter of the world's diabetes patients. With the change of living and eating habits, diabetes has become the third major factor affecting human health after ...
While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally. ...
RC48-ADC is a class of ADC drugs independently developed in China, which has shown certain antitumor activity in phase I studies applied in solid tumors, and the related toxic reactions and adverse events are also acceptable. ...
As a professional pharmaceutical intermediates and API supplier, Huateng Pharma has three SGLT-2 inhibitors in development: Dapagliflozin, Canagliflozin, Empagliflozin and their intermediates. Looking ahead, sales of SGLT-2 inhibitors are expected to grow further, and Huateng Pharma will focus on reducing the ...
TPD developed based on this technique degrades p-p38 protein. Post-translational modification (PTM) of p38 protein into phosphorylated p-p38 is associated with the occurrence and development of AD. ...
It has obvious antioxidant effect and has been used as a natural functional whitening raw material for cosmetics research and development. In 1978, Holder et al. proved that tetrahydrocurcumin has similar pharmacological effects to curcumin. ...
Prospect of ADC in PCa Biotechnology developments have improved the antibody specificity, linker stability and cytotoxic efficacy of novel ADCs, and ongoing clinical trials will evaluate the safety and efficacy of these novel ADCs in mCRPC. ...
Carfilzomib is a specific, irreversible targeted inhibitor originally developed by Proteolix, produced by Onyx Pharmaceuticals, and approved by the FDA on July 20, ...
Semaglutide, a one-drug, once-a-week injection, has also greatly increased patient satisfaction with treatment. Huateng Pharma is expert in manufacturing and development of pharmaceutical intermediates in its ultra-modern state of art facilities. We can provide pharmaceutical intermediates of semaglutide, such as ...
In recent years, the gene editing technology of CRISPR/Cas9 has developed rapidly, showing great potential in the fields of basic research and disease treatment. ...
A study conducted under the Lung Cancer Master Protocol (Lung-MAP) found that when treated with a combination of ramuzumab (Cyramza) and Keytruda, Patients with advanced NSCLC whose cancer progressed during prior immunotherapy lived significantly longer than when treated with one of the current standard therapies for this cancer. The hazard ratio (80% confidence interval) for overall survival ...
Clinical data show that SGLT2 inhibitors can prevent and treat nonalcoholic fatty liver disease to a certain extent. Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. After research and development, Huateng ...
On February 16, 2022, the data on Paxlovid previously published by Pfizer and submitted to the FDA were published in the New England Journal of Medicine (NEJM). This NEJM article published viral load data that Paxlovid reduced viral load by 0.868 log10 compared to controls for 5 days of treatment, which equates to a remarkable 7.38-fold reduction in viral load. This pivotal study (NCT04960202) ...
Skin pigmentation variations and discolorations can appear in the form of various dark spots, due to age, acne scars or other conditions, or obtained as a result of the overexposure to the sun’s harmful UV rays. Sometimes freckles, the small dots of highly concentrated skin pigmentation, could also be undesirable. Skin whitening, lightening and bleaching refer to the use of chemical ...